Jianqun Liao

847 total citations
14 papers, 642 citations indexed

About

Jianqun Liao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jianqun Liao has authored 14 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Jianqun Liao's work include Pancreatic and Hepatic Oncology Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Ubiquitin and proteasome pathways (3 papers). Jianqun Liao is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Ubiquitin and proteasome pathways (3 papers). Jianqun Liao collaborates with scholars based in United States, Slovakia and France. Jianqun Liao's co-authors include Shashikant Lele, Kunle Odunsi, Feng Qian, Paulette Mhawech‐Fauceglia, Amy Beck, Nana Tchabo, Wendy J. Huss, Xinhui Wang, Carl Morrison and Jeannine Villella and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Jianqun Liao

14 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianqun Liao United States 10 340 257 149 137 111 14 642
Isabelle Soubeyran France 14 369 1.1× 362 1.4× 168 1.1× 162 1.2× 38 0.3× 25 767
Jessica Godin-Ethier Canada 8 250 0.7× 198 0.8× 73 0.5× 208 1.5× 186 1.7× 11 635
Inès Chevolet Belgium 15 343 1.0× 517 2.0× 211 1.4× 320 2.3× 159 1.4× 21 980
Jessica L. Christenson United States 13 226 0.7× 259 1.0× 197 1.3× 96 0.7× 52 0.5× 23 521
Dongni Shi China 13 325 1.0× 114 0.4× 126 0.8× 57 0.4× 19 0.2× 23 472
Amy Loercher United States 11 367 1.1× 232 0.9× 150 1.0× 288 2.1× 15 0.1× 16 772
Nicholas J. Achille United States 13 508 1.5× 223 0.9× 193 1.3× 266 1.9× 12 0.1× 22 891
Yurong Zhang China 11 413 1.2× 199 0.8× 153 1.0× 135 1.0× 34 0.3× 32 656
Robert Newman United States 11 510 1.5× 168 0.7× 286 1.9× 65 0.5× 38 0.3× 24 776
Hechun Lin China 14 856 2.5× 178 0.7× 591 4.0× 67 0.5× 6 0.1× 21 1.1k

Countries citing papers authored by Jianqun Liao

Since Specialization
Citations

This map shows the geographic impact of Jianqun Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianqun Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianqun Liao more than expected).

Fields of papers citing papers by Jianqun Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianqun Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianqun Liao. The network helps show where Jianqun Liao may publish in the future.

Co-authorship network of co-authors of Jianqun Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Jianqun Liao. A scholar is included among the top collaborators of Jianqun Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianqun Liao. Jianqun Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Aljahdali, Ieman, et al.. (2021). Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX.. American Journal of Translational Research. 13(7). 7458–7474. 7 indexed citations
3.
Ling, Xiang, Wenjie Wu, Jianqun Liao, et al.. (2020). Sensitivity of colorectal or pancreatic cancers with high DDX5 and mutations in Kras and p53 genes to FL118 treatment.. Journal of Clinical Oncology. 38(15_suppl). e16102–e16102. 2 indexed citations
4.
5.
Qian, Feng, et al.. (2018). Abstract A35: Ovarian cancer stem cells subvert tumor-specific T cells by disrupting T cells’ metabolic fitness. Clinical Cancer Research. 24(15_Supplement). A35–A35. 1 indexed citations
6.
Ling, Xiang, Wenjie Wu, Chuandong Fan, et al.. (2018). An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 240–240. 43 indexed citations
7.
Kurenova, Elena, Manivannan Ethirajan, Jianqun Liao, et al.. (2014). Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer. Cancer Letters. 353(2). 281–289. 11 indexed citations
8.
Kurenova, Elena, Deniz A. Uçar, Jianqun Liao, et al.. (2014). A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells. Cell Cycle. 13(16). 2542–2553. 13 indexed citations
9.
Liao, Jianqun, Feng Qian, Nana Tchabo, et al.. (2014). Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism. PLoS ONE. 9(1). e84941–e84941. 290 indexed citations
10.
Kurenova, Elena, et al.. (2013). Demonstration of the efficacy of compound CFAK-C4 targeting FAK-VEGFR3 protein-protein interaction in gastric cancer.. Journal of Clinical Oncology. 31(15_suppl). e22143–e22143. 1 indexed citations
11.
Kurenova, Elena, et al.. (2013). The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth. Oncotarget. 4(10). 1632–1646. 24 indexed citations
12.
Qian, Feng, Jianqun Liao, Jeannine Villella, et al.. (2012). Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation. Cancer Immunology Immunotherapy. 61(11). 2013–2020. 48 indexed citations
13.
Qian, Feng, Jeannine Villella, Paul K. Wallace, et al.. (2009). Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer. Cancer Research. 69(13). 5498–5504. 118 indexed citations
14.
Tchabo, Nana, Paulette Mhawech‐Fauceglia, Otávia L. Caballero, et al.. (2009). Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.. PubMed. 9. 6–6. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Soubeyran Breakdown of academic impact, for papers by Jessica Godin-Ethier Breakdown of academic impact, for papers by Inès Chevolet Breakdown of academic impact, for papers by Jessica L. Christenson Breakdown of academic impact, for papers by Dongni Shi Breakdown of academic impact, for papers by Amy Loercher Breakdown of academic impact, for papers by Nicholas J. Achille Breakdown of academic impact, for papers by Yurong Zhang Breakdown of academic impact, for papers by Robert Newman Breakdown of academic impact, for papers by Hechun Lin
Rankless by CCL
2026